Literature DB >> 25225251

CrossTalk opposing view: Which technique for controlling resistant hypertension? Carotid sinus stimulation.

Jens Jordan1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25225251      PMCID： PMC4197999          DOI： 10.1113/jphysiol.2013.268078

Source DB:  PubMed          Journal:  J Physiol        ISSN： 0022-3751            Impact factor:   5.182


× No keyword cloud information.
  28 in total

1.  Baroreflex activation therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial.

Authors:  George L Bakris; Mitra K Nadim; Hermann Haller; Eric G Lovett; Jill E Schafer; John D Bisognano
Journal:  J Am Soc Hypertens       Date:  2012-02-15

2.  Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trial.

Authors:  Uta C Hoppe; Mathias-Christoph Brandt; Rolf Wachter; Joachim Beige; Lars Christian Rump; Abraham A Kroon; Adam W Cates; Eric G Lovett; Hermann Haller
Journal:  J Am Soc Hypertens       Date:  2012-06-12

3.  The effect of carotid sinus nerve stimulation on cardiovascular dynamics in man.

Authors:  E L Rothfeld; V Parsonnet; K V Raman; I R Zucker; R Tiu
Journal:  Angiology       Date:  1969-04       Impact factor: 3.619

4.  Systemic and renal-specific sympathoinhibition in obesity hypertension.

Authors:  Thomas E Lohmeier; Radu Iliescu; Boshen Liu; Jeffrey R Henegar; Christine Maric-Bilkan; Eric D Irwin
Journal:  Hypertension       Date:  2011-12-19       Impact factor: 10.190

5.  Renal responses to chronic suppression of central sympathetic outflow.

Authors:  Radu Iliescu; Eric D Irwin; Dimitrios Georgakopoulos; Thomas E Lohmeier
Journal:  Hypertension       Date:  2012-07-02       Impact factor: 10.190

6.  Hypertension treatment and control in five European countries, Canada, and the United States.

Authors:  Katharina Wolf-Maier; Richard S Cooper; Holly Kramer; José R Banegas; Simona Giampaoli; Michel R Joffres; Neil Poulter; Paola Primatesta; Birgitta Stegmayr; Michael Thamm
Journal:  Hypertension       Date:  2003-11-24       Impact factor: 10.190

7.  Renal sensory and sympathetic nerves reinnervate the kidney in a similar time-dependent fashion after renal denervation in rats.

Authors:  Jan Mulder; Tomas Hökfelt; Mark M Knuepfer; Ulla C Kopp
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-02-13       Impact factor: 3.619

8.  Chronic baroreflex activation restores spontaneous baroreflex control and variability of heart rate in obesity-induced hypertension.

Authors:  Radu Iliescu; Ionut Tudorancea; Eric D Irwin; Thomas E Lohmeier
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-08-02       Impact factor: 4.733

9.  Prolonged activation of the baroreflex produces sustained hypotension.

Authors:  Thomas E Lohmeier; Eric D Irwin; Martin A Rossing; David J Serdar; Robert S Kieval
Journal:  Hypertension       Date:  2004-01-05       Impact factor: 10.190

10.  Limited acute influences of electrical baroreceptor activation on insulin sensitivity and glucose delivery: a randomized, double-blind, crossover clinical study.

Authors:  Marcus May; Jelka Ahrens; Jan Menne; Hermann Haller; Joachim Beige; Siegfried Eckert; Jens Jordan; Stefan Engeli
Journal:  Diabetes       Date:  2014-03-19       Impact factor: 9.461
View more
  4 in total

1.  Rebuttal from Markus P. Schlaich, Yusuke Sata and Murray D. Esler.

Authors:  Markus P Schlaich; Yusuke Sata; Murray D Esler
Journal:  J Physiol       Date:  2014-09-15       Impact factor: 5.182

2.  Rebuttal from L. E. K. Ratcliffe, W. Pijacka, F. D. McBryde, A. P. Abdala, D. J. Moraes, P. A. Sobotka, E. C. Hart, K. Narkiewicz, A. K. Nightingale and J. F. R. Paton.

Authors:  L E K Ratcliffe; W Pijacka; F D McBryde; A P Abdala; D J Moraes; P A Sobotka; E C Hart; K Narkiewicz; A K Nightingale; J F R Paton
Journal:  J Physiol       Date:  2014-09-15       Impact factor: 5.182

Review 3.  Role of the Sympathetic Nervous System and Its Modulation in Renal Hypertension.

Authors:  Yusuke Sata; Geoffrey A Head; Kate Denton; Clive N May; Markus P Schlaich
Journal:  Front Med (Lausanne)       Date:  2018-03-29

Review 4.  Diet, Lifestyle and Cardiovascular Diseases: Linking Pathophysiology to Cardioprotective Effects of Natural Bioactive Compounds.

Authors:  Javad Sharifi-Rad; Célia F Rodrigues; Farukh Sharopov; Anca Oana Docea; Aslı Can Karaca; Mehdi Sharifi-Rad; Derya Kahveci Karıncaoglu; Gözde Gülseren; Ezgi Şenol; Evren Demircan; Yasaman Taheri; Hafiz Ansar Rasul Suleria; Beraat Özçelik; Kadriye Nur Kasapoğlu; Mine Gültekin-Özgüven; Ceren Daşkaya-Dikmen; William C Cho; Natália Martins; Daniela Calina
Journal:  Int J Environ Res Public Health       Date:  2020-03-30       Impact factor: 3.390
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.